收藏切换
In vitro metabolism and drug-drug interaction potential of IG-105, a novel antimicrotubule agent
收藏切换
PDF
Jing PANG1, Xin-xin HU1, Yue-ming WANG1, Cong-ran LI1, Xin-yi YANG1, Zong-ying LIU1, Lai-xing HU1, Dan-qing SONG1, Zhuo-rong LI1, Xue-fu YOU1, *, Jian-dong JIANG2, *
Acta Pharmaceutica Sinica | 2017, 52(6) : 921 - 927
Less
收藏切换
Acta Pharmaceutica Sinica | 2017, 52(6): 921-927
ORIGINAL ARTICLES·Pharmacology
In vitro metabolism and drug-drug interaction potential of IG-105, a novel antimicrotubule agent
Full
Jing PANG1, Xin-xin HU1, Yue-ming WANG1, Cong-ran LI1, Xin-yi YANG1, Zong-ying LIU1, Lai-xing HU1, Dan-qing SONG1, Zhuo-rong LI1, Xue-fu YOU1, *, Jian-dong JIANG2, *
Affiliations
  • 1. Beijing Key Laboratory of Antimicrobial Agents and Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2017-06-12 doi: 10.16438/j.0513-4870.2017-0467
Outline
收藏切换

IG-105, N-(2, 6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide, a novel antimicrotubule agent, showed potent anticancer activity in a variety of human tumor cells in vitro and in vivo. In order to characterize the metabolism and the possible drug-drug interaction of IG-105, we carried out a series of experiments. Drug metabolizing enzymes involved in IG-105 metabolism were investigated by using pooled human liver microsomes (HLMs) and recombinant cytochrome P450 isoforms (rP450s) respectively. The possible metabolites were analyzed by liquid chromatography-orbitrap-mass spectrometry (LC-Orbitrap-MS). The inhibitory effect of IG-105 on main P450 enzymes was also evaluated. The results showed that IG-105 can be metabolized by a series of rP450s, including CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4 and CYP3A5, with the major contribution enzymes being CYP1A2, CYP2B6, CYP2C19, and CYP3A. Three metabolites (M1-M3) were identified and demethylation was the major phase I metabolic reaction for IG-105. IG-105 moderately inhibited CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A enzyme activities with IC50 values of 6.42, 23.64, 0.39, 1.4, and 3.14 μmol·L-1, respectively. Since the biotransformation of IG-105 involves multiple enzymatic pathways, the compound is less likely to be a victim of a concomitantly used medicine which inhibits activity of one of the CYPs. However, as IG-105 showed medium to strong inhibition on CYP1A2, CYP2D6, CYP3A, and CYP2C19, caution is particularly needed when IG-105 is co-administrated with other anticancer drugs which are mainly metabolized by the above enzymes.

IG-105  /  anticancer  /  in vitro metabolism  /  drug-drug interaction
Jing PANG, Xin-xin HU, Yue-ming WANG, Cong-ran LI, Xin-yi YANG, Zong-ying LIU, Lai-xing HU, Dan-qing SONG, Zhuo-rong LI, Xue-fu YOU, Jian-dong JIANG. In vitro metabolism and drug-drug interaction potential of IG-105, a novel antimicrotubule agent[J]. Acta Pharmaceutica Sinica, 2017 , 52 (6) : 921 -927 . DOI: 10.16438/j.0513-4870.2017-0467
Year 2017 volume 52 Issue 6
PDF
112
35
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2017-0467
  • Receive Date:2017-05-10
  • Online Date:2026-01-14
  • Published:2017-06-12
Article Data
Affiliations
History
  • Received:2017-05-10
  • Revised:2017-05-18
Funding
Affiliations
    1. Beijing Key Laboratory of Antimicrobial Agents and Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2017-0467
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT